Theseparadoxical observations appear to have been resolved by genetic studiesshowing that the heterozygous disruption of PPARγ is sufficient to increase tumor numberin AOM-treated mice and that intestinal-specific PPARγ knockout promotes tumor growthin ApcMin/+ mice [39, 51]. This evidence concerns the gene PPARG and neoplasm.